Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Assets (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Return on Assets for 12 consecutive years, with 0.17% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 3.0% to 0.17% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.17%, a 3.0% increase, with the full-year FY2025 number at 0.2%, up 6.0% from a year prior.
  • Return on Assets was 0.17% for Q4 2025 at Niagen Bioscience, down from 0.22% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.22% in Q3 2025 to a low of 0.57% in Q2 2022.
  • A 5-year average of 0.14% and a median of 0.11% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -5bps in 2022, then soared 40bps in 2023.
  • Niagen Bioscience's Return on Assets stood at 0.46% in 2021, then rose by 18bps to 0.37% in 2022, then skyrocketed by 75bps to 0.09% in 2023, then skyrocketed by 245bps to 0.14% in 2024, then rose by 24bps to 0.17% in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Return on Assets are 0.17% (Q4 2025), 0.22% (Q3 2025), and 0.21% (Q2 2025).